Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David M. Poetker is active.

Publication


Featured researches published by David M. Poetker.


Otolaryngologic Clinics of North America | 2010

A comprehensive review of the adverse effects of systemic corticosteroids

David M. Poetker; Douglas D. Reh

Corticosteroids are widely used in otolaryngology to treat many disorders; however, the nature and extent of possible complications may not be completely understood. A comprehensive review of the physiology of systemic corticosteroids and literature discussing the known side effects associated with their use is presented. The pathophysiology and the clinical impact of these side effects are reviewed. There are various potential side effects from the use of corticosteroids. Practitioners using corticosteroids should be familiar with these and obtain the patients informed consent when appropriate.


American Journal of Rhinology | 2007

Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonasal polyposis

David M. Poetker; Sabrina Mendolia-Loffredo; Timothy L. Smith

Background The aim of this study was is to investigate the outcomes of endoscopic sinus surgery (ESS) when performed for chronic rhinosinusitis associated with sinonasal polyps. Methods Forty-three patients with polyps were compared with 76 patients without polyps before and after ESS. Mean follow-up was 1.5 years. Patients were analyzed prospectively based on computed tomography (CT), endoscopy, quality-of-life (QOL) assessment, and visual analog scales (VASs). Univariate analyses were performed to evaluate whether the presence of polyps was predictive of outcome. Results Patients with polyps had worse CT and endoscopy scores both pre- and postoperatively when compared with patients without polyps (p < 0.0001 for each). All patients, regardless of polyps, improved on endoscopic exam; however, patients with polyps showed a greater degree of improvement (p = 0.002). Despite this, postoperative endoscopic scores in patients with polyps were worse than those without polyps (p < 0.0001). Patients with polyps had better QOL as measured by the Chronic Sinusitis Survey (CSS) both pre- and postoperatively (p = 0.001 and 0.044, respectively). The preoperative VAS indicated that patients with polyps had increased nasal obstruction compared with patients without polyps (p = 0.002) while having less facial pain and headache (p = 0.002 and 0.005, respectively). Patients with polyps showed a greater postoperative improvement in nasal congestion (p = 0.003) but no difference in level of improvement in postoperative headache or pressure. Conclusion Despite significantly worse objective testing scores, patients with polyps report significantly better QOL as measured by the CSS and less facial pain/headache as measured by VAS scores pre- and postoperatively. Polyps were not found to be predictive of QOL or endoscopic outcome.


Otolaryngology-Head and Neck Surgery | 2010

Medical Malpractice and Corticosteroid Use

John J. Nash; Amanda G. Nash; Matthew E. Leach; David M. Poetker

Objective. To analyze malpractice litigation trends related to the administration of corticosteroids and the reported complications. Study Design. Retrospective. Setting. Tertiary medical center. Subjects and Methods. The WESTLAW database was reviewed from March 1996 to November 2008. Data were compiled on the demographics of the defendant, plaintiff, expert witness specialty, allegation, complication, indication for steroids, verdict, and judgment. Results. Eighty-three cases met inclusion criteria and were selected for review. The most common conditions for which steroids were prescribed were pain (23%), asthma or another pulmonary condition (20%), a dermatologic condition (18%), a nondermatologic autoimmune condition (17%), and allergies (6%). Allegation of negligent use was the most common reason for a suit being filed (65%), followed by lack of proper informed consent (36%), failure to diagnose or misdiagnosis (22%), multiple allegations (25%), and wrongful death (4%). Verdicts for the defendant predominated (59%), whereas 24 cases (29%) were found for the plaintiff, and 10 cases (12%) settled out of court. The range of monetary awards was from


International Forum of Allergy & Rhinology | 2013

Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations.

David M. Poetker; Luke A. Jakubowski; Devyani Lal; Peter H. Hwang; Erin D. Wright; Timothy L. Smith

25 000 to


American Journal of Rhinology | 2005

Endoscopic management of sinonasal tumors: a preliminary report.

David M. Poetker; Robert J. Toohill; Todd A. Loehrl; Timothy L. Smith

8.1 million. Complications reported were often multiple and included avascular necrosis (39%), mood changes (16%), visual complaints (14%), and infectious complications (14%). Three cases involved otolaryngologists. Conclusion. Although other specialties were more often involved in suits, otolaryngologists frequently prescribe corticosteroids and must be diligent in explaining potential side effects of steroids. The informed consent process, documentation, and close monitoring of patients are critical to avoid potential litigation.


International Forum of Allergy & Rhinology | 2016

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

Richard R. Orlandi; Todd T. Kingdom; Peter H. Hwang; Timothy L. Smith; Jeremiah A. Alt; Fuad M. Baroody; Pete S. Batra; Manuel Bernal-Sprekelsen; Neil Bhattacharyya; Rakesh K. Chandra; Alexander G. Chiu; Martin J. Citardi; Noam A. Cohen; John M. DelGaudio; Martin Desrosiers; Hun Jong Dhong; Richard Douglas; Berrylin J. Ferguson; Wytske J. Fokkens; Christos Georgalas; Andrew Goldberg; Jan Gosepath; Daniel L. Hamilos; Joseph K. Han; Richard J. Harvey; Peter Hellings; Claire Hopkins; Roger Jankowski; Amin R. Javer; Robert C. Kern

Oral steroids are commonly used in the management of chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP, respectively). Past reports have included evaluation of the evidence for the use of oral steroids in CRS subtypes. However, a review with evidence‐based recommendations for all CRS subtypes has never been performed. The purpose of this article is to provide a comprehensive, evidence‐based approach for the utilization of oral steroids in the management of CRS.


Otology & Neurotology | 2004

Complication rate of transtemporal hydroxyapatite cement cranioplasties: A case series review of 76 cranioplasties

David M. Poetker; Kristen Pytynia; Glenn A. Meyer; P. Ashley Wackym

Background The increased experience with the endoscopic approach to sinonasal inflammatory disease has resulted in the increased use of endoscopes to manage many different sinonasal pathologies. Methods A chart review of patients with sinonasal tumors treated with primary endoscopic management, from January, 1993 to November, 2003 was performed. Results Forty patients were identified (26 men and 14 women). The mean age was 53.2 years, and the mean follow-up was 31.1 months. For benign tumors, 24 patients were identified with a mean age of 50.7 years, a mean follow-up of 17.5 months, and a recurrence rate of 4.2%. For malignant tumors, 16 patients were identified, with a mean age of 57.3 years, a mean follow-up of 51.5 months, and a recurrence rate of 31.3%. The overall survival rate was 87.5%. Conclusion Endoscopic surgical excision of selective sinonasal tumors may be an effective therapeutic modality. In some cases, adjuvant external procedures may be required based on tumor location.


Current Opinion in Otolaryngology & Head and Neck Surgery | 2007

Adult chronic rhinosinusitis: surgical outcomes and the role of endoscopic sinus surgery.

David M. Poetker; Timothy L. Smith

Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham, MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav Chawdhary, MD7, Philip Chen, MD8, John P. Dahl, MD, PhD9, Anthony Del Signore, MD10, Carrie Flanagan, MD11, Daniel N. Frank, PhD12, Kai Fruth, MD, PhD13, Anne Getz, MD14, Samuel Greig, MD15, Elisa A. Illing, MD16, David W. Jang, MD17, Yong Gi Jung, MD18, Sammy Khalili, MD, MSc19, Cristobal Langdon, MD20, Kent Lam, MD21, Stella Lee, MD22, Seth Lieberman, MD23, Patricia Loftus, MD24, Luis Macias‐Valle, MD25, R. Peter Manes, MD26, Jill Mazza, MD27, Leandra Mfuna, MD28, David Morrissey, MD29, Sue Jean Mun, MD30, Jonathan B. Overdevest, MD, PhD31, Jayant M. Pinto, MD32, Jain Ravi, MD33, Douglas Reh, MD34, Peta L. Sacks, MD35, Michael H. Saste, MD36, John Schneider, MD, MA37, Ahmad R. Sedaghat, MD, PhD38, Zachary M. Soler, MD39, Neville Teo, MD40, Kota Wada, MD41, Kevin Welch, MD42, Troy D. Woodard, MD43, Alan Workman44, Yi Chen Zhao, MD45, David Zopf, MD46


International Forum of Allergy & Rhinology | 2012

What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: a review of the literature†

David M. Poetker; Timothy L. Smith

Objective: The objective of this study was to evaluate the complication rate of transtemporal cranioplasties using hydroxyapatite cement (HAC) for repair. Study Design: We conducted a retrospective case review of patients receiving HAC cranioplasties in the Acoustic Neuroma and Skull Base Surgery Program between July 1998 and December 2002. Setting: This study was conducted at a tertiary referral center. Patients: A total of 76 HAC cranioplasties were performed in 72 patients undergoing lateral skull base surgery. Patients undergoing anterior skull base surgery or those in which HAC was used for other reconstructive purposes were excluded from the study. Interventions: We studied transtemporal approaches for otologic procedures requiring cranioplasty. Main Outcome Measures: Main outcomes measures consisted of complications requiring medical or surgical intervention. Results: Of the 76 HAC cranioplasties, two cranioplasty grafts became infected, requiring explantation. The first case involved a wound infection that extended into and involved the HAC graft; the second involved seeding of the HAC graft after meningitis after a percutaneous, endoscopic gastrostomy tube placement performed several days after the primary skull base surgery. This gives our series a wound infection incidence rate of 1.3% and an overall complication incidence rate of 2.63%. Conclusions: This retrospective review provides the largest series to date evaluating the incidence of infection in HAC cranioplasties. Despite having a much larger series, our complication rate is the lowest published rate of HAC cranioplasty explantation, and the incidence of superficial wound infections reported here is consistent with the published data for neurosurgical and neurotologic procedures.


Otolaryngology-Head and Neck Surgery | 2005

Association of airway abnormalities and risk factors in 37 subglottic stenosis patients.

David M. Poetker; Sandra L. Ettema; Joel H. Blumin; Robert J. Toohill; Albert L. Merati

Purpose of reviewTo review the recent literature as to the role of and data supporting endoscopic sinus surgery for the treatment of adult chronic rhinosinusitis. Recent findingsMany studies have been published evaluating patient responses to endoscopic sinus surgery. These responses have included subjective measures such as patient-reported symptoms, and subjective symptoms measured objectively, as seen with quality-of-life instruments. Others have used objective measures such as endoscopy scores, medication use and financial impact to measure responses to surgery. These studies have varying follow-up, with patients followed for up to several years postsurgery. The results are very consistent, with most studies reporting improvement in both subjective and objective findings postoperatively. SummaryThe data in the literature clearly support the use of functional endoscopic sinus surgery in cases of chronic rhinosinusitis refractory to medical therapy. Surgery has been shown to improve patient symptoms, quality of life and intranasal endoscopic exam.

Collaboration


Dive into the David M. Poetker's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Todd A. Loehrl

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Ashley Wackym

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Robert J. Toohill

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Joel H. Blumin

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John S. Rhee

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Joseph E. Kerschner

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge